Citius Pharmaceuticals (CTXR) Tax Provisions (2022 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Tax Provisions came in at -$231210.0 in Q1 2026, down 187.5% YoY from $264240.0 in Q1 2025, and down 187.5% on a QoQ basis from $264240.0 in Q4 2025.
Citius Pharmaceuticals (CTXR) Tax Provisions (2022 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 5 years of Tax Provisions data on file, last reported at -$231210.0 in Q1 2026.
- Quarterly Tax Provisions fell 187.5% year-over-year to -$231210.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $561510.0 (down 31.23% YoY) and the FY2025 annual result came in at $1.1 million, up 83.5% from the prior year.
- Tax Provisions slipped to -$231210.0 in Q1 2026, from $264240.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $264240.0 in Q4 2024 to a low of -$231210.0 in Q1 2026.
- A 5-year average of $160142.1 and a median of $144000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2024 — Tax Provisions surged 83.5% — and 2026, when it slumped 187.5%.
- Tracing CTXR's Tax Provisions over 5 years: stood at $144000.0 in 2022, then changed by 0.0% to $144000.0 in 2023, then surged by 83.5% to $264240.0 in 2024, then changed by 0.0% to $264240.0 in 2025, then tumbled by 187.5% to -$231210.0 in 2026.
- The last three Tax Provisions figures came in at -$231210.0 (Q1 2026), $264240.0 (Q4 2025), and $264240.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | Citius Pharmaceuticals | 15.60 Mn | 15.60 Mn | 1.00 Mn | -107,347.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -231,210.00 |
| Dec 31, 2025 | 264,240.00 |
| Sep 30, 2025 | 264,240.00 |
| Jun 30, 2025 | 264,240.00 |
| Mar 31, 2025 | 264,240.00 |
| Dec 31, 2024 | 264,240.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Mar 31, 2024 | 144,000.00 |
| Dec 31, 2023 | 144,000.00 |
| Sep 30, 2023 | 144,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 144,000.00 |